In previous studies involving in vitro assays, LDD-2614 exhibited FLT3 inhibition, anti-proliferative activity in the AML line of MV4-11 cells, and significant in vivo antitumor activity in a MV4-11 xenograft animal model [22]. Here, FLT3 is linked to acute myeloid leukemia.